Patients with urologic cancers of the prostate, bladder, kidney, testis, and related organs are evaluated and managed with emphasis on an integrated, multidisciplinary and stage-specific approach. A full range of conventional and advanced or novel treatments are provided, including: robotic and minimally invasive surgery for a wide variety of urologic cancers; radical cystectomy and continent urinary diversion; nerve sparing techniques for cancers of the prostate; nephron-sparing surgery; chemotherapy or molecular target therapy for advanced or metastatic urologic cancers; conventional conformal radiation therapy, intensity modulated radiation therapy and brachytherapy.
|Associate Professors||Akira Komiya||Takashi Imamoto|
|Staff||Shinichi Sakamoto||Yusuke Imamura|
|Kazuyoshi Nakamura||Akira Kurozumi|